Trinity Street Asset Management LLP Grows Holdings in The Cigna Group (NYSE:CI)

Trinity Street Asset Management LLP raised its holdings in shares of The Cigna Group (NYSE:CIFree Report) by 7.1% in the 3rd quarter, HoldingsChannel.com reports. The institutional investor owned 81,411 shares of the health services provider’s stock after acquiring an additional 5,397 shares during the period. The Cigna Group comprises about 2.8% of Trinity Street Asset Management LLP’s portfolio, making the stock its 8th largest holding. Trinity Street Asset Management LLP’s holdings in The Cigna Group were worth $28,204,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also recently modified their holdings of the stock. Cedar Wealth Management LLC purchased a new position in shares of The Cigna Group in the first quarter worth $29,000. TruNorth Capital Management LLC purchased a new position in shares of The Cigna Group in the second quarter valued at about $33,000. Ulland Investment Advisors LLC raised its stake in shares of The Cigna Group by 2,500.0% during the third quarter. Ulland Investment Advisors LLC now owns 104 shares of the health services provider’s stock valued at $36,000 after acquiring an additional 100 shares during the last quarter. Thurston Springer Miller Herd & Titak Inc. purchased a new stake in shares of The Cigna Group during the second quarter worth about $66,000. Finally, Private Ocean LLC grew its stake in shares of The Cigna Group by 29.9% in the second quarter. Private Ocean LLC now owns 200 shares of the health services provider’s stock worth $66,000 after purchasing an additional 46 shares during the last quarter. 86.99% of the stock is owned by institutional investors.

Insider Buying and Selling

In related news, Director William J. Delaney III sold 2,691 shares of the stock in a transaction on Monday, August 19th. The stock was sold at an average price of $342.68, for a total transaction of $922,151.88. Following the sale, the director now directly owns 17,539 shares of the company’s stock, valued at $6,010,264.52. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. 0.60% of the stock is owned by company insiders.

Analyst Upgrades and Downgrades

A number of research analysts have commented on CI shares. Cantor Fitzgerald reaffirmed an “overweight” rating and set a $400.00 price target on shares of The Cigna Group in a research report on Wednesday, October 23rd. StockNews.com upgraded The Cigna Group from a “buy” rating to a “strong-buy” rating in a report on Friday, August 2nd. Royal Bank of Canada reiterated an “outperform” rating and issued a $384.00 price target on shares of The Cigna Group in a report on Monday, September 9th. Stephens restated an “overweight” rating and issued a $410.00 price objective on shares of The Cigna Group in a report on Friday, August 2nd. Finally, Barclays lifted their target price on shares of The Cigna Group from $393.00 to $405.00 and gave the company an “overweight” rating in a research note on Friday, August 2nd. One analyst has rated the stock with a hold rating, thirteen have issued a buy rating and two have given a strong buy rating to the company. According to data from MarketBeat.com, The Cigna Group has an average rating of “Buy” and an average price target of $392.79.

Check Out Our Latest Report on CI

The Cigna Group Stock Down 1.0 %

Shares of NYSE CI traded down $3.22 on Tuesday, reaching $311.70. 662,686 shares of the company’s stock traded hands, compared to its average volume of 1,497,789. The business’s 50 day simple moving average is $348.42 and its two-hundred day simple moving average is $342.46. The Cigna Group has a 12 month low of $253.95 and a 12 month high of $370.83. The company has a market cap of $88.55 billion, a price-to-earnings ratio of 25.86, a price-to-earnings-growth ratio of 1.05 and a beta of 0.50. The company has a quick ratio of 0.71, a current ratio of 0.71 and a debt-to-equity ratio of 0.73.

The Cigna Group (NYSE:CIGet Free Report) last posted its quarterly earnings results on Thursday, August 1st. The health services provider reported $6.72 earnings per share for the quarter, topping the consensus estimate of $6.42 by $0.30. The company had revenue of $60.52 billion for the quarter, compared to the consensus estimate of $58.30 billion. The Cigna Group had a return on equity of 17.83% and a net margin of 1.70%. The firm’s quarterly revenue was up 24.6% compared to the same quarter last year. During the same quarter in the prior year, the business posted $6.13 EPS. As a group, equities research analysts forecast that The Cigna Group will post 28.48 EPS for the current fiscal year.

The Cigna Group Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Thursday, December 19th. Investors of record on Wednesday, December 4th will be given a dividend of $1.40 per share. This represents a $5.60 annualized dividend and a dividend yield of 1.80%. The ex-dividend date of this dividend is Wednesday, December 4th. The Cigna Group’s dividend payout ratio (DPR) is currently 45.98%.

About The Cigna Group

(Free Report)

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.

Featured Stories

Want to see what other hedge funds are holding CI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Cigna Group (NYSE:CIFree Report).

Institutional Ownership by Quarter for The Cigna Group (NYSE:CI)

Receive News & Ratings for The Cigna Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for The Cigna Group and related companies with MarketBeat.com's FREE daily email newsletter.